Compare Charter Communications Inc (CHTR) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charter Communications Inc vs IDEXX Laboratories, Inc. — how do they compare? Charter Communications Inc trades at $150 (market cap $18.81B), while IDEXX Laboratories, Inc. trades at $572 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 2.5× Charter Communications Inc's market cap. Which is the better fit depends on your goals.
| CHTR | IDXX | |
|---|---|---|
Market Cap | $18.81B | $46.22B |
Sector | Media | Health |
52-Week High | $282.74 | $766.68 |
52-Week Low | $123.31 | $526.44 |
Enterprise Value | $115.01B | $47.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charter Communications (CHTR) trades at $153.29, up 0.47% today, near its pivot point of $152. The stock shows mixed technical signals with a bullish moving average trend but bearish oscillators. Fundamentally, it trades at low valuation multiples (P/E 4.1, P/S 0.37) with solid profitability (ROE 29.7%, net margin 9.05%), though Q1 2026 earnings missed expectations. Recent news highlights debt refinancing activities and competitive pressures in broadband.
Outlook: CHTR presents a value opportunity with deep discount to historical multiples, supported by strong cash flow and buybacks, but faces headwinds from subscriber losses and high debt load. Risks include fiber competition and revenue declines, while analyst consensus leans bullish with a $166.18 price target.
IDEXX Laboratories (IDXX) trades at $595.76, up 1.55% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $4.27 versus $3.94 expected, driven by 9% organic revenue growth. The company raised full-year EPS guidance to $14.69–14.94, reflecting robust demand in companion animal diagnostics. Valuation ratios remain elevated with a P/E of 41.23, supported by high profitability margins including a net income margin of 25.03% and ROE of 74.21%.
Outlook is positive given consistent earnings beats, international expansion, and product innovation, but risks include premium valuation sensitivity and competitive pressures. The consensus price target of $683.33 implies 14.7% upside, with 57% of analysts rating it Buy. Investors should weigh growth durability against high multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charter Communications Inc
Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 54 million U.S. homes and businesses, around 40% of the country. Across this footprint, Charter serves 29 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest U.S. cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.
Read more on CHTR →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
